Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients

OBJECTIVE: The present study investigated long-term outcomes of medroxyprogesterone acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC), and post-treatment conception. METHODS: We retrospectively analyzed 63 patients (42 with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsuhashi, Akira, Habu, Yuji, Kobayashi, Tatsuya, Kawarai, Yoshimasa, Ishikawa, Hiroshi, Usui, Hirokazu, Shozu, Makio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779615/
https://www.ncbi.nlm.nih.gov/pubmed/31576686
http://dx.doi.org/10.3802/jgo.2019.30.e90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779615/
https://www.ncbi.nlm.nih.gov/pubmed/31576686
http://dx.doi.org/10.3802/jgo.2019.30.e90

Ejemplares similares